Agriculture Biotechnology Market by Type of Organism (Plant, Animal, and Microbes), Type, Technology, Application, and Region - Global Forecast to 2030 The global agriculture biotechnology market was valued at USD 84.39 billion in 2024 and is projected to reach USD 144.25 billion by 2030, growing at a compound annual growth rate (CAGR) of 9.4% during 2025–2030. Market growth is fueled by the rising adoption of genetically modified (GM) crops, microbial biofertilizers, animal vaccines, and sustainable biote ...

European Companies - BASF Group reported Q3 2025 sales of €15.23 billion (approximately $17.7 billion), down 3.2% year-on-year from €15.739 billion. Operating profit (EBIT) increased by 11.4% to €278 million, while net profit fell by 40% to €172 million [1] - LyondellBasell's Q3 2025 sales and other revenues were $7.727 billion, down from $8.604 billion year-on-year. The company reported a net loss of $890 million compared to a net profit of $573 million in the same period last year [2] - INEOS Group Holdings reported Q3 2025 revenue of €3.418 billion (approximately $3.97 billion), down from €4.273 billion year-on-year. Operating profit decreased to €113 million from €339 million, with a net loss of €56.5 million compared to a profit of €283 million last year [3] - Evonik Group's Q3 2025 sales were €3.391 billion (approximately $3.94 billion), down from €3.832 billion year-on-year. Adjusted EBITDA fell to €448 million from €577 million, with a net loss of €106 million compared to a net profit of €223 million [4] - Covestro reported Q3 2025 sales of €3.171 billion (approximately $3.68 billion), down 12% from €3.603 billion. EBITDA decreased by 15.7% to €242 million, with a net loss of €47 million compared to a net profit of €33 million last year [5] - DSM-Firmenich's Q3 2025 sales were €3.07 billion (approximately $3.57 billion), down 5% from €3.244 billion. Adjusted EBITDA remained stable at €540 million [6] - Sika reported Q3 2025 sales of CHF 3.078 billion (approximately $3.4 billion), down 3.8% from CHF 3.915 billion. EBITDA decreased to CHF 1.645 billion from CHF 1.702 billion, with net profit falling to CHF 871 million from CHF 923 million [8] - Henkel's Q3 2025 sales fell by 6.3% to €5.147 billion, with the adhesives technology division reporting sales of approximately $3.145 billion, down 3.3% year-on-year [9] - Arkema's Q3 2025 sales were €2.187 billion (approximately $2.54 billion), down 8.6% from €2.394 billion. EBITDA fell by 23.8% to €310 million, with adjusted net profit down 53.6% to €78 million [10] - Syensqo reported Q3 2025 sales of €1.517 billion (approximately $1.76 billion), down 7.1% from €1.633 billion. EBITDA decreased by 12.8% to €326 million, with net profit down 31.8% to €110 million [11] - LANXESS reported Q3 2025 sales of €1.338 billion (approximately $1.55 billion), down 16.3% from €1.598 billion. EBITDA fell by 35.6% to €105 million, with a net loss of €77 million compared to a profit of €1 million last year [12] - Solvay's Q3 2025 sales were €1.044 billion (approximately $1.21 billion), down 9.7% from €1.156 billion. EBITDA decreased by 10.3% to €232 million, with net profit down 15% to €88 million [13] - Clariant reported Q3 2025 sales of CHF 906 million (approximately $1.03 billion), down 9% from CHF 991 million. EBITDA increased by 14% to CHF 159 million [14] Asian Companies - Rongsheng Petrochemical reported Q3 2025 revenue of ¥79.185 billion (approximately $11.2 billion), down 5.67% year-on-year. Net profit attributable to shareholders was ¥286 million, up 1427.94% [15] - SABIC's Q3 2025 revenue was SAR 34.333 billion (approximately $9.147 billion), down from SAR 36.88 billion year-on-year. Operating profit decreased to SAR 1.663 billion from SAR 2.477 billion, with net profit falling to SAR 1.135 billion from SAR 1.763 billion [16] - Hengli Petrochemical reported Q3 2025 revenue of ¥53.496 billion (approximately $7.67 billion), down 17.98% year-on-year. Net profit attributable to shareholders was ¥1.972 billion, up 81.47% [17] - Wanhua Chemical reported Q3 2025 revenue of ¥53.324 billion (approximately $7.54 billion), up 5.52% year-on-year. Net profit attributable to shareholders was ¥3.035 billion, up 3.96% [18] - Mitsubishi Chemical Group reported H1 2025 revenue of ¥1,799.124 billion (approximately $11.5 billion), down 10.5% year-on-year. Operating profit decreased by 19.6% to ¥86.489 billion, with net profit attributable to shareholders up 169% to ¥110.132 billion [19] - Taiwan Chemical announced Q3 2025 revenue of NT$69.576 billion (approximately $2.22 billion), down from NT$86.899 billion. The company reported a net profit of NT$1.78 billion, compared to a net loss of NT$1.918 billion last year [20] - Nanya Plastics reported Q3 2025 revenue of NT$64.2 billion (approximately $2.04 billion), down from NT$66.4 billion. Operating profit increased to NT$1.04 billion from NT$990 million, with net profit rising to NT$4 billion from NT$490 million [21] - Formosa Plastics reported Q3 2025 revenue of NT$41.718 billion (approximately $1.33 billion), down from NT$50.492 billion. The company reported a net loss of NT$2.685 billion, compared to a loss of NT$3.092 billion last year [22] - Asahi Kasei Corporation reported H1 2025 revenue of ¥1,486.368 billion (approximately $9.54 billion), down slightly from ¥1,490.334 billion. Operating profit increased to ¥108.915 billion from ¥107.454 billion, while net profit decreased to ¥60.248 billion from ¥66.266 billion [23] - Dongfang Shenghong reported Q3 2025 revenue of ¥31.245 billion (approximately $4.5 billion), down 11.91% year-on-year. The company reported a net loss of ¥260 million [24] - Shin-Etsu Chemical reported H1 2025 revenue of ¥1,284.522 billion (approximately $8.24 billion), up 1.4% year-on-year. Operating profit decreased by 17.7% to ¥333.935 billion, with net profit down 12.3% to ¥257.844 billion [25] - Toray reported H1 2025 revenue of ¥1,234.31 billion (approximately $7.92 billion), down 4.6% year-on-year. Operating profit decreased by 19.1% to ¥642.99 billion, with net profit down 33.5% to ¥369.35 billion [26] - Hengyi Petrochemical reported Q3 2025 revenue of ¥27.925 billion (approximately $3.95 billion), down 7.07% year-on-year. Net profit attributable to shareholders was ¥4.4079 million, up 102.21% [27] - LG Chem reported Q3 2025 sales of ₩111.962 trillion (approximately $76.24 billion), down 11.3% from ₩126.2 trillion. Operating profit increased by 38.9% to ₩6.797 trillion, while net profit fell to ₩4.470 trillion from ₩10.13 trillion [28] American Companies - Dow reported Q3 2025 net sales of $9.973 billion, down from $10.879 billion year-on-year. Net profit attributable to common shareholders was $62 million, down from $214 million [36] - Ecolab reported Q3 2025 net sales of $4.165 billion, up from $3.999 billion year-on-year. Operating profit decreased by 27% to $760 million, with net profit down 21% to $585 million [37] - DuPont reported Q3 2025 net sales of $3.072 billion, up from $2.862 billion year-on-year. The company reported a net loss of $123 million, compared to a profit of $455 million last year [39] - Westlake Corporation reported Q3 2025 net sales of $2.838 billion, down from $3.117 billion. The company reported an operating loss of $766 million, compared to a profit of $180 million last year [40] - IFF reported Q3 2025 net sales of $2.694 billion, down from $2.925 billion year-on-year. Operating profit decreased by 9% to $226 million, with net profit down to $40 million from $58 million [41] - Celanese reported Q3 2025 net sales of $2.419 billion, down from $2.648 billion. The company reported an operating loss of $1.275 billion, compared to a profit of $245 million last year [42] - Eastman Chemical Company reported Q3 2025 sales of $2.202 billion, down from $2.464 billion. Net profit attributable to the company was $47 million, down from $180 million [43] - Huntsman Corporation reported Q3 2025 revenue of $1.46 billion, down from $1.54 billion. The company reported a net loss of $25 million, compared to a loss of $33 million last year [44] Industrial Gases - Linde plc reported Q3 2025 sales of $8.615 billion, up from $8.356 billion year-on-year. Operating profit increased to $2.367 billion from $2.086 billion, with net profit rising to $1.929 billion from $1.55 billion [45] - Air Liquide reported Q3 2025 revenue of €6.599 billion (approximately $7.66 billion), down from €6.762 billion year-on-year [46] - Air Products & Chemicals reported Q4 2025 sales of $3.167 billion, down from $3.188 billion. The company reported an operating profit of $16.8 million, down from $242.4 million last year, with a net profit of $4.9 million compared to $195 million [47] Crop Science - Syngenta Group reported Q3 2025 revenue of $6.4 billion, down 6% year-on-year. EBITDA increased by 28% to $900 million [48] - Bayer Group reported Q3 2025 sales of €9.66 billion, down from €9.968 billion. EBIT loss was €543 million, compared to a loss of €382.2 million last year, with a net loss of €963 million compared to a loss of €4.183 billion last year [49] - Corteva, Inc. reported Q3 2025 net sales of $2.618 billion, up from $2.326 billion year-on-year. The company reported a net loss of $320 million, compared to a loss of $524 million last year [50] Fertilizers - Nutrien reported Q3 2025 sales of $6.007 billion, up from $5.348 billion year-on-year. Net profit increased to $469 million from $25 million [51] - Yara International ASA reported Q3 2025 revenue of $4.108 billion, up from $3.654 billion. Operating profit increased to $470 million from $309 million, with net profit rising to $320 million from $286 million [52] - The Mosaic Company reported Q3 2025 net sales of $3.452 billion, up from $2.811 billion. Operating profit increased to $340 million from $115 million, with net profit rising to $411 million from $122 million [53] - CF Industries reported Q3 2025 net sales of $1.659 billion, up from $1.37 billion. Net profit attributable to common shareholders was $353 million, compared to $276 million last year [54] Coatings - PPG Industries reported Q3 2025 net sales of $4.082 billion, up from $4.032 billion year-on-year, with net profit remaining stable at $444 million [55] - AkzoNobel reported Q3 2025 revenue of €2.547 billion (approximately $2.96 billion), down from €2.668 billion. The company reported an operating loss of €29 million, compared to a profit of €259 million last year, with a net loss of €194 million compared to a profit of €163 million last year [56] - Nippon Paint Holdings reported YTD revenue of ¥1,318.378 billion (approximately $8.467 billion), up 7.8% year-on-year. Operating profit increased by 36.4% to ¥190.579 billion, with net profit rising by 38.6% to ¥134.336 billion [57] - Sherwin-Williams reported Q3 2025 net sales of $6.358 billion, up from $6.163 billion. Net profit increased to $833 million from $806 million, with the paint retail group reporting sales of $3.837 billion, up 5.1% [58] - Axalta Coating Systems Ltd. reported Q3 2025 net sales of $1.288 billion, down from $1.32 billion. Operating profit increased to $204 million from $193 million, with net profit rising to $110 million from $101 million [59] - Three Trees reported YTD revenue of ¥9.392 billion (approximately $1.33 billion), up 2.69% year-on-year. Net profit attributable to shareholders was ¥744 million, up 81.22% [60]

Core Insights - Corteva, Inc. (CTVA) is a leading agricultural company with a market cap of $44.3 billion, providing seed and crop protection solutions along with digital services [1][2] Company Overview - CTVA is classified as a large-cap stock, emphasizing its significant size and influence in the agricultural inputs industry [2] - The company boasts a strong product pipeline and focuses on global agrarian needs through science-based innovations, operating in 125 countries for regional customization [2] - CTVA employs a flexible production strategy to ensure cost efficiency and adaptability to market demand [2] Stock Performance - CTVA's stock has declined 15.6% from its 52-week high of $77.41, with a 9.8% drop over the past three months, underperforming the S&P 500 Index's 6.2% gains [3] - Over the last six months, CTVA shares fell 8.3%, while gaining 5.3% over the past 52 weeks, lagging behind the S&P 500's six-month and one-year gains of 14.7% and 13.2%, respectively [4] - The stock has been trading below its 200-day moving average since early October but above its 50-day moving average since mid-November [4] Financial Performance - In Q3, CTVA reported an adjusted loss of $0.23 per share, outperforming Wall Street's expectation of a $0.49 loss, with revenue of $2.6 billion exceeding the forecast of $2.5 billion [5] - The company projects full-year adjusted EPS between $3.25 and $3.35, with revenue expectations ranging from $17.7 billion to $17.9 billion [5] Competitive Landscape - CTVA's competitor, FMC Corporation, has experienced significant stock declines, with a 66.2% drop over six months and 77.2% over the past year, highlighting CTVA's relative strength in the market [6]

Industry Background: Transition to a "Data-Driven" Era in Breeding - Traditional breeding relies heavily on time-consuming field trials and personal experience, typically requiring 7-12 years for completion, which is costly and has a limited success rate. The global breeding industry is undergoing a fundamental shift from "experience-driven" to "data + model-driven" due to the significant decrease in genome sequencing costs, widespread application of high-throughput phenotyping technologies, and continuous enhancement of AI computing power [2]. Core Applications of AI in the Breeding Industry - **Genomic Selection**: This technology analyzes vast amounts of genetic markers to accurately predict key traits such as crop yield, quality, and disease resistance. AI can reduce the breeding cycle from 7-10 years to 4-6 years and improve trait prediction accuracy by 10-25%, while significantly lowering field validation costs. Leading companies like Bayer and KWS have implemented this at scale for major crops [6]. - **Phenotypic Analysis**: AI enhances the efficiency and accuracy of collecting phenotypic data through automated analysis of plant growth, disease severity, and canopy structure using drones and hyperspectral cameras. This technology increases selection efficiency by 5-10 times and provides objective quantitative data for field trials [7]. - **Hybrid Combination Prediction**: AI integrates multi-dimensional data to improve the accuracy of predicting successful hybrid combinations, addressing the issue where over 95% of traditional combinations fail to meet expectations. This allows for the early elimination of ineffective combinations, focusing resources on high-potential materials [8]. - **Environmental Modeling**: AI constructs G×E (genotype × environment) models to predict how different genotypes perform in various environments, facilitating a shift from reliance on multi-site trials to model-driven predictions, thus overcoming geographical limitations in breeding [10]. Global Application Status: From Experimental Exploration to Large-Scale Implementation - The global breeding industry has formed three distinct tiers in AI application: - Leading seed companies like Bayer and Syngenta have established comprehensive data infrastructures and AI breeding systems, creating high technical barriers [12]. - Research institutions such as CGIAR and USDA are driving innovation in AI breeding projects for staple crops, providing theoretical and technical support [13]. - Small and medium enterprises are gaining capabilities through SaaS platforms, allowing them to access advanced breeding tools at lower costs [13]. Commercialization Models and Industry Transformation Directions - Three main commercialization models have emerged in AI breeding: - **SaaS Software Subscription Model**: Targets small and medium breeding companies, offering tiered pricing based on image processing volume or trial area, lowering the application threshold for AI technology [15]. - **Data Analysis Service Model**: Provides specialized services for specific breeding projects, converting professional knowledge into value [15]. - **AI-Driven New Variety Commercialization**: This mainstream model for seed companies enhances breeding efficiency, leading to faster market introduction and more stable traits, ultimately increasing seed sales revenue [15]. Future Prospects: AI Will Reshape the Global Breeding Competitive Landscape - The breeding industry is expected to undergo three distinct development stages driven by AI: - **Short-term (1-3 years)**: Rapid commercialization of single-point AI tools, with phenotypic analysis AI leading the way and genomic selection solidifying its mainstream status [17]. - **Mid-term (3-7 years)**: AI will evolve from single-point tools to a full-process breeding system, with digital field trials becoming common and hybrid combination prediction transitioning into routine production [17]. - **Long-term (7-10 years)**: The deep integration of AI with gene editing technologies will create a closed-loop system, significantly reducing breeding costs by 40-60% and shortening cycles by 30-50% [17]. Domestic Development Status: Breakthroughs in China's AI Breeding Field - The year 2025 is projected to be a landmark year for China's AI breeding, with several innovative achievements: - The Shanghai AI Laboratory, in collaboration with other institutions, launched the first autonomous scientific discovery system in biological breeding, capable of simulating molecular biologist functions [19]. - Zhejiang University and Huawei developed an "AI Breeder" that enhances cotton hybrid breeding efficiency by 20 times and reduces the breeding cycle from 6-8 years to 3-4 years [19]. - The establishment of a unified data platform by the Qiaozhou Bay National Laboratory and Huawei significantly improves breeding efficiency through standardized data collection [19]. Conclusion: AI Initiates the "Second Revolution" in the Breeding Industry - AI is leading the most profound transformation in the breeding industry since the advent of hybrid breeding technology, marking a shift from reliance on experience to data-driven predictions. This revolution fundamentally changes the breeding paradigm from "art" to "science," establishing quantifiable and predictable mathematical models [21]. The integration of AI with gene editing technologies will usher in an era of "precise design" in breeding, redefining competitive dynamics in the global seed industry [21].

Core Insights - IBI Ag successfully completed its Series A funding round, raising a total of $10 million to advance its bioinsecticide platform [1][3]. Funding Details - The investment was led by Corteva through its Corteva Catalyst platform, with participation from The Trendlines Group, Iron Nation, Consensus Business Group, and a grant from the Israel Innovation Authority, along with Bandera Capital and First Imagine Ventures [2]. Company Milestone - The completion of the Series A funding marks a significant milestone for IBI Ag, highlighting the global recognition of its innovative antibody-based bioinsecticide platform [3]. Technology Overview - IBI Ag's proprietary technology utilizes single-domain antibodies (nanobodies) to develop effective and selective biological insect control products, aimed at protecting high-value crops while minimizing environmental impact [4][6]. Leadership Statements - The CEO of IBI Ag expressed pride in gaining investor confidence and emphasized the company's readiness to bring its biological solutions to farmers globally, enhancing productivity and sustainability [5]. - A senior director at Corteva highlighted the collaboration as a means to deliver innovative and sustainable crop protection solutions [5].

Core Viewpoint - Corteva, Inc. is a global agricultural company specializing in seeds and crop protection products, with the stock previously rated as a Hold due to fair pricing [1] Company Overview - Corteva, Inc. operates in the farming sector, focusing on the production of seeds and crop protection solutions [1] Investment Focus - The analysis primarily targets small- to mid-cap companies, which are often overlooked by investors, while also occasionally reviewing large-cap companies for a broader market perspective [1]

Core Insights - Corteva, Inc. is a global agricultural company specializing in seeds and crop protection products, with a previous stock rating of Hold due to fair pricing [1] Company Overview - Corteva focuses on producing objective, data-driven research primarily on small- to mid-cap companies, while occasionally analyzing large-cap companies for a broader market perspective [1]

Financial Performance - The company reported net sales of $2,618 million for Q3 2025, a 13% increase compared to $2,326 million in Q3 2024, driven by a 12% increase in volume and a 2% favorable currency impact, partially offset by a 1% decline in price [212][213]. - For the nine months ended September 30, 2025, net sales were $13,491 million, up 4% from $12,930 million in the same period last year, reflecting a 5% increase in volume and a 1% increase in price, partially offset by a 2% unfavorable currency impact [216][217]. - Income from continuing operations after income taxes for Q3 2025 was $(308) million, an improvement from $(519) million in the same quarter last year [212]. - Income from continuing operations after income taxes for the nine months ended September 30, 2025, was $1,741 million, up from $913 million in the same period of 2024 [271]. - The company reported a diluted earnings per share of $(0.46) for Q3 2025, compared to $(0.76) in Q3 2024, while for the nine months ended September 30, 2025, it was $2.54, up from $1.29 in 2024 [276]. Cost and Expenses - Cost of goods sold (COGS) for Q3 2025 was $1,644 million, representing 63% of net sales, compared to $1,565 million (67% of net sales) in Q3 2024, driven by higher volumes and lower commodity prices [220]. - COGS for the nine months ended September 30, 2025, was $6,918 million (51% of net sales), down from $7,033 million (54% of net sales) in the same period last year, due to ongoing cost and productivity actions and lower commodity prices [221]. - Research and Development (R&D) expenses were $351 million (13% of net sales) for Q3 2025, slightly up from $348 million (15% of net sales) in Q3 2024, reflecting increased employee compensation costs [222]. - Selling, General and Administrative (SG&A) expenses were $725 million (28% of net sales) for Q3 2025, compared to $671 million (29% of net sales) in Q3 2024, primarily due to increased commissions and variable compensation [223]. - SG&A expenses increased to $2,632 million (20% of net sales) for the nine months ended September 30, 2025, compared to $2,461 million (19% of net sales) for the same period in 2024 [224]. Shareholder Returns - The company returned approximately $1.1 billion to shareholders during the nine months ended September 30, 2025, through share repurchase programs and common stock dividends [211]. - In January 2025, the company authorized a common stock dividend of $0.17 per share, increasing to $0.18 per share in July 2025, reflecting a 5.9% increase [294]. - Corteva, Inc. announced a $3 billion share repurchase program on November 19, 2024, with 3,401,000 shares repurchased for $250 million and 3,681,000 shares for $270 million during the three and nine months ended September 30, 2025, respectively [295]. - The company completed a $2 billion share repurchase program in Q2 2025, repurchasing 7,815,000 shares for $500 million during the nine months ended September 30, 2025 [296]. - For the full year 2025, the company expects approximately $1 billion in share repurchases under the 2024 and 2022 Share Buyback Plans [297]. Segment Performance - Seed segment net sales increased to $917 million for the three months ended September 30, 2025, from $691 million in 2024, and $8,161 million for the nine months ended September 30, 2025, compared to $7,773 million in 2024 [251]. - Segment operating EBITDA for the Seed segment improved to $(193) million for the three months ended September 30, 2025, from $(320) million in 2024, and increased to $2,512 million for the nine months ended September 30, 2025, compared to $2,126 million in 2024 [251]. - Crop Protection net sales were $1,701 million in Q3 2025, a 4% increase from $1,635 million in Q3 2024, driven by a 5% increase in volume and a 1% favorable currency impact [261]. - Segment operating EBITDA for Crop Protection was $279 million in Q3 2025, up 13% from $246 million in Q3 2024, with margin improvement of approximately 135 basis points [263]. - Crop Protection net sales for the first nine months of 2025 were $5,330 million, up 3% from $5,157 million in the same period of 2024, with a 7% increase in volume [264]. Cash Flow and Liquidity - Cash provided by operating activities for continuing operations was $(941) million for the nine months ended September 30, 2025, an improvement from $(1,871) million in the same period of 2024 [290]. - Cash used for investing activities was $(355) million for the nine months ended September 30, 2025, compared to $(466) million in 2024, driven by reduced capital expenditures [292]. - Cash provided by financing activities was $554 million for the nine months ended September 30, 2025, a decrease from $2,137 million in 2024, primarily due to higher borrowings in 2024 [293]. - The company had access to approximately $6.3 billion in unused credit lines as of September 30, 2025, providing support for short-term liquidity needs [280]. - Total debt increased to $4,373 million as of September 30, 2025, from $2,703 million at December 31, 2024, primarily due to the issuance of Senior Notes in May 2025 [278]. Tax and Other Financial Metrics - The effective tax rate for the nine months ended September 30, 2025, was 21.5% on pre-tax income of $2,218 million, compared to 23.1% on pre-tax income of $1,187 million for the same period in 2024 [234][235]. - Significant items after tax for the nine months ended September 30, 2025, resulted in a benefit of $14 million, compared to a charge of $(219) million in the same period of 2024 [272]. - Other income (expense) improved to $(23) million for the three months ended September 30, 2025, compared to $(107) million in 2024, and $95 million for the nine months ended September 30, 2025, versus $(319) million in 2024 [228][229]. - Interest expense decreased to $46 million for the three months ended September 30, 2025, down from $66 million in 2024, and $134 million for the nine months ended September 30, 2025, compared to $173 million in 2024 [231]. Corporate Developments - The company announced its intent to separate its seed and crop protection businesses into two standalone, publicly traded companies, intended to be a tax-free spin-off for U.S. federal income tax purposes [210]. - The company has not reported any material changes to its contractual obligations outside the ordinary course of business since the 2024 Annual Report [304]. - The company is subject to market risk and utilizes financial instruments, with disclosures available in the 2024 Annual Report [305].

Core Insights - Corteva has announced the launch of two new crop protection solutions, Goltrevo and Varpelgo, aimed at combating destructive pests affecting various crops [2][3] Group 1: Product Details - Goltrevo is a bioinsecticide based on a novel strain of the fungus Beauveria bassiana 203, targeting sap-feeding insects like corn leafhoppers, whiteflies, and aphids, as well as chewing insects such as root-feeding worms and caterpillars [3][9] - Varpelgo provides effective control of chewing insects, including diamondback moths and armyworms, and is designed for key crops like soybeans, corn, and rice [5][6] Group 2: Market and Regulatory Aspects - Commercial sales of Goltrevo are expected to begin in 2027 in Latin America, pending regulatory approvals [4] - Varpelgo is anticipated to see its first commercial sales in the early 2030s in Asia Pacific and Latin America, subject to field trials and regulatory reviews [6] Group 3: Strategic Importance - The introduction of these products aligns with Corteva's commitment to innovation in crop protection, enhancing farmer productivity and supporting global food security [3][8] - Both products are designed to fit within integrated pest management programs, offering farmers new rotational choices for pest control [6]

Core Points - The article emphasizes the importance of enabling Javascript and cookies in browsers to prevent access issues [1] - It highlights that users with ad-blockers may face restrictions when trying to access content [1] Summary by Categories Technical Requirements - Users are advised to enable Javascript and cookies in their browsers to ensure proper functionality [1] - The presence of ad-blockers can lead to blocked access, necessitating their temporary disablement [1]